The life sciences industry is moving decisively from net-zero ambition to execution. As regulatory pressure intensifies and energy costs rise, pharmaceutical, biotech, and medical device companies must decarbonise their operations—without compromising compliance, product quality, or operational resilience. The 5th Net-Zero Life Sciences Forum 2026 brings together industry leaders to address this critical shift. The event focuses on practical, real-world strategies for decarbonising manufacturing, energy systems, and supply chains—covering everything from energy sourcing and process optimisation to Scope 3 transformation and CAPEX decision-making. Moving beyond engineering-led discussions, the forum delivers strategic, operational, and financial insights to help organisations build resilient, low-carbon pharma operations at scale.